The 16-Year Dividend Streak Inside a $4 Billion Materials Maker

16 straight years of raises from a materials maker posting record marginsSixteen straight years of dividend hikes, from a specialty materials maker with record margins.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Read online       Unsubscribe       The 16-Year Dividend Streak Inside a $4 Billion Materials Maker A specialty materials maker extended its dividend-growth streak to 16 years this week. The stock has cooled off from its high just as Q3 approaches, and I think you'll want to see this one. Meet the Pick Avient Corporation (NYSE: AVNT). Cleveland-based. Specialty materials. Market cap around $3.8 billion. Shares are up more than 25% this year but have cooled about 11% from their 52-week high over the past month. Avient makes polymer colorants, additives, specialty engineered materials, and inks. The stuff shows up inside packaging, consumer goods, car parts, and medical devices. Boring on the surface. Steady underneath. And on Tuesday, the board handed you its 16th straight annual dividend hike. Nuclear Demand Builds (Sponsored) Nuclear Stocks With Real Revenue Growth For years, investors ignored nuclear energy. The numbers have since moved. One uranium producer generated nearly $200 million in quarterly free cash flow. Another nuclear-focused company locked in long-term government contracts that pushed revenue higher. Energy reliability and supply constraints have kept demand tightening. Yet many stocks tied to the sector still trade as if nothing has changed. 7 Top Nuclear Stocks to Buy Now names seven companies across the sector, from uranium producers with commodity upside to contract-backed nuclear services names. Download the report free today. (By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our Privacy Policy. Unsubscribe at any time.) The Boring Business Doing the Interesting Work Here's what you're really buying when you buy Avient: formulation expertise. They don't make the plastic. They make the thing that gives the plastic its color, its UV resistance, its anti-microbial properties, its flame retardance. High-margin layer of the chain. Sits inside stuff you touch every day without a second thought. Why does this matter now? Specialty chemicals just lived through two miserable years. Destocking, soft European demand, lumpy consumer-goods volumes, the works. The group got clobbered. Avient didn't escape. But the business has already turned. On August 6, Avient beat Q2 estimates with adjusted EPS up 20% to $0.96 and a record 18.3% adjusted EBITDA margin, and it raised full-year guidance. Tuesday's hike, from $0.275 to $0.2825 a quarter ($1.10 to $1.13 a year), tells you the board expects that strength to hold. Boards don't raise payouts into a deteriorating business. They hoard cash. Why the Numbers Still Work Avient runs asset-light compared to its upstream chemical peers. That matters a lot when raw material prices go on a joyride. They've got pricing power on the formulation side, and they don't carry the capital intensity of a bulk producer. Through cycles, that's historically meant a more defensive margin profile you can lean on. Scale check: at about $3.8 billion, Avient is a small-cap, and the stock trades at roughly 12 times forward earnings. Let end-market demand keep normalizing, and the operating leverage flows straight to the bottom line. Action block: Build the position before Q3 lands on November 4, not after. The $39 to $42 range is your anchor. Any constructive guidance on 2027 margins could push the multiple higher. McDonald's, now a Dividend King with 45+ years of increases, paid its first-ever dividend in what year? 1965 1976 1985 1995 Fortress Yields (Sponsored) Strong earnings. Growing payouts. Durable demand. The 7 Stocks to Buy and Hold Forever aren't just plays for the next quarter - they're built to deliver for decades. These are blue-chip companies with fortress balance sheets, elite dividend track records, and the staying power to outperform in bull and bear markets alike. Some are Dividend Kings; others are on the path there. Whether you're after steady income, capital growth, or both, this is the list long-term investors will want in their back pocket. Download the full list now. (By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) Where the Tailwinds Are Hiding Three structural shifts are working in Avient's favor. The stock's run this year prices in some of that, but not all of it. - Packaging demand recovery. CPG customers burned through excess inventory in 2025 and into early 2026. Reorders are firming up. Avient sells into every category that benefits. - Healthcare specialty materials. Medical device makers need specific polymer formulations with regulatory traceability. Sticky revenue, higher margin, keeps growing. - Transportation lightweighting. Automakers chasing weight reduction for emissions and EV range targets are swapping metal for specialty polymer compounds. Avient has real IP here. None of this is pie-in-the-sky stuff. These are grinding, multi-year trends that show up in revenue a little at a time. The only question is whether you want the exposure before Q3 confirms the inflection, or after. What the Fundamentals Actually Say The core argument isn't that earnings are about to blow the doors off. It's that you're paying about 12 times forward earnings for a business that just posted record margins and raised guidance. Here's the pattern you want to see going into Q3: stabilizing organic volumes, gross margin holding, and management reiterating or raising the 2026 adjusted EBITDA outlook. Check those three boxes and the stock has room to run back toward its 52-week high near $47 without any heroic assumptions. The dividend raise tells you management has the cash to back it up. Early Signals (Sponsored) You think you're locked out of this IPO. Half right. You assume you're locked out of Anthropic. You're half right. Pre-IPO shares are closed — no secondary platform, no early allocation. The public side is different. Good Morning Alerts' analyst identified 3 companies trading on regular exchanges with real ties to Anthropic's growth: two mega-caps holding billion-dollar stakes, and a smaller supplier in its critical path. See the setup before the crowd arrives  *This ad is sent on behalf of Stable Financial Publishing, LLC, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing in IPOs and equities involves substantial risk, including loss of principal; past performance and projections do not guarantee future results. Valuation and timing figures are third-party reports and investor expectations, not company guidance. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/ The Dividend You Are Actually Buying Here's the part that matters most if you're building an income sleeve. Avient's new quarterly dividend of $0.2825 annualizes to $1.13. At today's price near $41, that works out to a yield of about 2.7%. The headline yield isn't what makes this interesting. The trajectory is. Sixteen straight annual increases don't happen by accident. It's a cultural commitment. And it survived the pandemic, the 2022 input-cost spike, and the 2024-25 destocking slog. The payout runs about a third of expected adjusted earnings, so the company can keep raising even if earnings stay flattish for a quarter or two. That's the kind of dividend you want in a portfolio built to compound. Action block: If you want income today AND dividend growth over the next decade, this is the kind of name you accumulate on weakness and let it do its work. Reinvest the dividends and add on pullbacks toward $39. What Could Blow This Up Fair warning on the risks. A few actually matter. European industrial demand is still soft, and Avient has meaningful exposure over there. If the ECB stays restrictive longer than expected, your 2027 top-line estimates get walked down. Raw material volatility, specifically on specialty resins and pigments, can squeeze gross margins when the company can't pass costs through fast enough. Auto end-markets are cyclical. Any sharper slowdown in global auto builds dings a chunk of the specialty engineered materials line you're counting on. And the honest one. If Q3 disappoints, this stock doesn't have a mega-cap sponsorship base to catch the fall. Another 10 to 15 percent downside before buyers show up is entirely possible. That's why the entry zone matters. And why you size accordingly. Putting It All Together Avient isn't flashy. It won't double in a quarter. What you get is a 16-year dividend-growth story inside a specialty materials business that still trades at about 12 times forward earnings. This week's hike is management's signal that fundamentals are better than the share price suggests. The setup into Q3 looks tight. If you're building a dividend portfolio and you want names where the compounding has decades still to run, this one fits. Enter on weakness. Let the dividend do the heavy lifting while the operating cycle turns. Treat the November 4 earnings print as the next catalyst. That's the trade. Setup Scorecard Entry Zone: $39 to $42 Target: $48 over 12 to 18 months as margins normalize Stop Loss: Reassess if shares close below $36  Catalyst Timeline: Q3 2026 earnings on November 4, before the open; first payment at the new $0.2825 rate in early January 2027 Confidence Level: Medium. Thesis hinges on end-market normalization and a Q3 print confirming stabilization. Dividend durability is high. Price catalyst timing, less so. That’s all for today’s edition of the Dividend Brief. Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email! —Noah Zelvis DividendBrief.com   Dividend Brief is a publication of Elite Trade Media LLC. Disclosure: Content is for informational and entertainment purposes only and is not investment advice. Do not base investment decisions on this newsletter. Securities mentioned may be owned by our owners or operators, which could affect our objectivity. Consult a licensed financial advisor before making any investment decision. We may receive compensation from advertisers and affiliate links in this email, including for featured third-party offers. Dividend Brief and its parent company are not registered investment advisors, broker-dealers, or financial planners. Nothing published by Dividend Brief — including but not limited to newsletters, emails, text messages, social media posts, or website content — constitutes personalized investment advice, a recommendation to buy or sell any security, or an offer or solicitation to purchase or sell any financial instrument. All content is provided strictly for informational and educational purposes. You should not rely on any content published by Dividend Brief as a substitute for professional financial, legal, or tax advice tailored to your individual circumstances. Always consult a qualified, licensed financial advisor before making any investment decision. Forward-Looking Statements: Content may contain forward-looking statements, including projections, opinions, and expectations regarding future events or financial performance. These statements are based on current information and assumptions at the time of writing and are inherently uncertain. Actual results may differ materially. Dividend Brief is under no obligation to update or revise any forward-looking statement after publication. No Guarantee of Accuracy: While Dividend Brief strives for accuracy, we make no representation or warranty — express or implied — regarding the completeness, reliability, or timeliness of any information provided. Errors, omissions, and outdated information may occur. All content is provided "as is" without warranty of any kind. Past Performance: Any reference to past performance of a security, strategy, or index is not indicative of future results. All investments carry risk, including the potential loss of principal. You could lose some or all of your invested capital. Editorial Process Disclosure: Dividend Brief uses proprietary research tools, including AI, in its editorial process. All content is reviewed and approved by our editorial team before publication. Readers should independently verify any information before making financial decisions. Advertising & Affiliate Disclosure: Dividend Brief receives compensation from third-party advertisers and may include paid promotions, sponsored content, and affiliate links within its publications. When you click on certain links or sign up for third-party services featured in our content, we may receive a commission or flat fee. This compensation may influence which companies or products are covered and how they are presented, though it does not affect our editorial opinions. Sponsored content is provided by advertisers and does not represent the views of Dividend Brief. Conflicts of Interest: Contributors, editors, and affiliates of Dividend Brief may hold positions in securities discussed in our content. These positions may be established or liquidated at any time without notice to readers. Limitation of Liability: Under no circumstances shall Dividend Brief, its owners, employees, affiliates, or contributors be liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of or reliance on any content published by Dividend Brief. By reading, subscribing to, or otherwise engaging with Dividend Brief content, you acknowledge and agree to the terms above. Update your email preferences or unsubscribe here © 2026 Elite Trade Media LLC 1032 E Brandon Blvd #9644 Brandon, FL 33511, United States